Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bowden

Showing results (381-390 of 444) with videos related to

Pageof 45
Sort By:
BMC Musculoskeletal Disorders|May 2, 2018
Effectiveness of a new model of primary care management on knee pain and function in patients with knee osteoarthritis: Protocol for THE PARTNER STUDYDavid J Hunter, Rana S Hinman, Jocelyn L Bowden, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2019
The implications of hypersomnia in the context of major depression: Results from a large, international, observational studyA Murru, G Guiso, M Barbuti, et al.
Journal of Affective Disorders|July 13, 2013
Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trialsE S Friedman, J R Calabrese, T A Ketter, et al.
The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.
Osteoarthritis and Cartilage|April 17, 2025
The cost-effectiveness of guideline-recommended treatments for osteoarthritis: A systematic reviewStephanie Mathieson, Giovanni Ferreira, Caitlin Jones, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Osteoarthritis and Cartilage Open|September 29, 2023
The OARSI Joint Effort Initiative: Priorities for osteoarthritis management program implementation and research 2024-2028Jocelyn L Bowden, David J Hunter, Kathryn Mills, et al.
Pageof 45

Showing results (381-390 of 444) with videos related to

Sort By:
Pageof 45
BMC Musculoskeletal Disorders|May 2, 2018
Effectiveness of a new model of primary care management on knee pain and function in patients with knee osteoarthritis: Protocol for THE PARTNER STUDYDavid J Hunter, Rana S Hinman, Jocelyn L Bowden, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2019
The implications of hypersomnia in the context of major depression: Results from a large, international, observational studyA Murru, G Guiso, M Barbuti, et al.
Journal of Affective Disorders|July 13, 2013
Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trialsE S Friedman, J R Calabrese, T A Ketter, et al.
The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.
Osteoarthritis and Cartilage|April 17, 2025
The cost-effectiveness of guideline-recommended treatments for osteoarthritis: A systematic reviewStephanie Mathieson, Giovanni Ferreira, Caitlin Jones, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Osteoarthritis and Cartilage Open|September 29, 2023
The OARSI Joint Effort Initiative: Priorities for osteoarthritis management program implementation and research 2024-2028Jocelyn L Bowden, David J Hunter, Kathryn Mills, et al.
Pageof 45